Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amer A Beg

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Biology|November 15, 2006
Bid-independent mitochondrial activation in tumor necrosis factor alpha-induced apoptosis and liver injuryXiaoyun Chen, Wen-Xing Ding, Hong-Min Ni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Differential requirement for the IKKβ/NF-κB signaling module in regulating TLR- versus RLR-induced type 1 IFN expression in dendritic cellsXingyu Wang, Junmei Wang, Hong Zheng, et al.
JTO Clinical and Research Reports|October 10, 2024
Unveiling the Molecular Features of SCLC With a Clinical RNA Expression PanelHilal Ozakinci, Aileen Y Alontaga, Pedro Cano, et al.
Bioinformatics (Oxford, England)|April 26, 2021
TIMEx: tumor-immune microenvironment deconvolution web-portal for bulk transcriptomics using pan-cancer scRNA-seq signaturesMengyu Xie, Kyubum Lee, John H Lockhart, et al.
Carcinogenesis|July 11, 2013
TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancerMatthew B Schabath, Anna R Giuliano, Zachary J Thompson, et al.
Nature Communications|August 18, 2019
Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesisTao Han, Shulong Jiang, Hong Zheng, et al.
Nature Cell Biology|October 5, 2011
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respirationClaudio Mauro, Shi Chi Leow, Elena Anso, et al.
Cancer Research|November 26, 2009
Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myelomaDanielle N Yarde, Vasco Oliveira, Linda Mathews, et al.
Plos One|July 1, 2021
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancerDung-Tsa Chen, Wenyaw Chan, Zachary J Thompson, et al.
Cancer Research|December 19, 2025
Distinct Tumor-Immune Ecologies in Lung Cancer Patients Predict Progression and Define a Clinical Biomarker of Therapy ResponseSandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Biology|November 15, 2006
Bid-independent mitochondrial activation in tumor necrosis factor alpha-induced apoptosis and liver injuryXiaoyun Chen, Wen-Xing Ding, Hong-Min Ni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2014
Differential requirement for the IKKβ/NF-κB signaling module in regulating TLR- versus RLR-induced type 1 IFN expression in dendritic cellsXingyu Wang, Junmei Wang, Hong Zheng, et al.
JTO Clinical and Research Reports|October 10, 2024
Unveiling the Molecular Features of SCLC With a Clinical RNA Expression PanelHilal Ozakinci, Aileen Y Alontaga, Pedro Cano, et al.
Bioinformatics (Oxford, England)|April 26, 2021
TIMEx: tumor-immune microenvironment deconvolution web-portal for bulk transcriptomics using pan-cancer scRNA-seq signaturesMengyu Xie, Kyubum Lee, John H Lockhart, et al.
Carcinogenesis|July 11, 2013
TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancerMatthew B Schabath, Anna R Giuliano, Zachary J Thompson, et al.
Nature Communications|August 18, 2019
Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesisTao Han, Shulong Jiang, Hong Zheng, et al.
Nature Cell Biology|October 5, 2011
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respirationClaudio Mauro, Shi Chi Leow, Elena Anso, et al.
Cancer Research|November 26, 2009
Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myelomaDanielle N Yarde, Vasco Oliveira, Linda Mathews, et al.
Plos One|July 1, 2021
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancerDung-Tsa Chen, Wenyaw Chan, Zachary J Thompson, et al.
Cancer Research|December 19, 2025
Distinct Tumor-Immune Ecologies in Lung Cancer Patients Predict Progression and Define a Clinical Biomarker of Therapy ResponseSandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi, et al.
Pageof 6